2024-11-05 |
Acquired bla(CfxA-3) carried by a conjugative transposon or duplicated intrinsic bla(CME-3) mediates cefiderocol resistance in Elizabethkingia anophelis clinical isolates |
International Journal of Antimicrobial Agents. 2024 Nov 05;Article in Press. |
|
2024-08-06 |
Changing epidemiology and antimicrobial resistance of bacteria causing bacteremia in Taiwan: 2002-2020 |
Microbiology Spectrum. 2024 Aug 6;12(8):Article number e0060824. |
|
2024-08 |
Imipenem reduces the efficacy of vancomycin against Elizabethkingia species |
Journal of Antimicrobial Chemotherapy. 2024 Aug 1;79(8):2048-2052. |
|
2024-07-10 |
Clonal expansion of Tn1546-like transposon-carrying vancomycin-resistant Enterococcus faecium, a nationwide study in Taiwan, 2004-2018 |
Journal of Global Antimicrobial Resistance. 2024 Jul 10;39:100-108. |
|
2024-07 |
The individual contributions of blaB, blaGOB and blaCME on MICs of Beta-lactams in Elizabethkingia anophelis |
Journal of Antimicrobial Chemotherapy. 2024 Jul;79(7):1577-1580. |
|
2024-01 |
In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species |
Journal of Antimicrobial Chemotherapy. 2024 Jan 3;79(1):200-202 |
|
2023-11-28 |
Elizabethkingia anophelis outer membrane vesicles as a novel vaccine candidate against infection: Insights into immune response and potential for passive immunity |
mSphere. 2023 Nov 28;Article number e0040023. |
|
2023-08 |
High-level levofloxacin-resistant emm12 group A Streptococcus, 2012–2018: A multicenter study in Taiwan |
Journal of Microbiology, Immunology and Infection. 2023 Aug;56(4):875-879. |
|
2022-11 |
Contribution of testing strategies and contact tracing towards COVID-19 outbreaks control: A mathematical modeling study |
Tropical Medicine and Infectious Disease. 2022 Nov;7(11):Article number 376. |
|
2022-09-16 |
Biofilm formation is not an independent risk factor for mortality in patients with Acinetobacter baumannii bacteremia |
Frontiers in Cellular and Infection Microbiology. 2022 Sep 16;12:Article number 964539. |
|
2022-05-25 |
A comprehensive evaluation of COVID-19 policies and outcomes in 50 countries and territories |
Scientific Reports. 2022 May 25;12:Article number 8802. |
|
2022-05-16 |
Discrimination of methicillin-resistant staphylococcus aureus by MALDI-TOF mass spectrometry with machine learning techniques in patients with staphylococcus aureus bacteremia |
Pathogens. 2022 May 16;11(5):Article number 586. |
|
2022-05-01 |
In vitro and in vivo comparison of eravacycline- and tigecycline-based combination therapies for tigecycline-resistant Acinetobacter baumannii |
Journal of Chemotherapy. 2022 May 01;34(3):166-172. |
|
2022-04 |
The prediction values of carbapenemase detection methods and carbapenem susceptibility testing for clinical outcomes of patients with Acinetobacter bacteremia under carbapenem treatment |
Journal of Microbiology, Immunology and Infection. 2022 Apr;55(2):257-265. |
|
2021-08-06 |
In vitro activity of imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan |
Journal of Antimicrobial Chemotherapy. 2021 Aug 6;76(8):2071-2078. |
|
2021-08 |
Mobile resistomes of human pathogens in swine wastewater treatment plants |
Journal of Microbiology, Immunology, and Infection. 2021 Aug;54(4):752-754. |
|
2021-06-14 |
Antimicrobial resistance mechanisms and virulence of colistin-and carbapenem-resistant acinetobacter baumannii isolated from a teaching hospital in Taiwan |
Microorganisms. 2021 Jun 14;9(6):Article number 1295. |
|
2021-04-13 |
Multicentre study of risk factors for mortality in patients with acinetobacter bacteraemia receiving colistin treatment[Erratum:International Journal of Antimicrobial Agents. 2020 Jun;55(6):Article number 105956.] |
International Journal of Antimicrobial Agents. 2021 Apr 13;57(5):Article number 106333. |
|
2021-03 |
Susceptibility of Elizabethkingia spp. to commonly tested and novel antibiotics and concordance between broth microdilution and automated testing methods |
Journal of Antimicrobial Chemotherapy. 2021 Mar;76(3):653-658. |
|
2021-02 |
Emergence of mcr-1, mcr-3, and mcr-8 in clinical Klebsiella pneumoniae isolates in Taiwan |
Clinical Microbiology and Infection. 2021 Feb;27(2):305-307. |
|
2021-02 |
In vitro and in vivo activities of imipenem combined with BLI-489 against class D Beta-lactamase-producing Acinetobacter baumannii |
Journal of Antimicrobial Chemotherapy. 2021 Feb;76(2):451-459. |
|
2021-02 |
Clinical and molecular characterization of Acinetobacter seifertii in Taiwan |
Journal of Antimicrobial Chemotherapy. 2021 Feb;76(2):312-321. |
|
2021-01 |
Nonpolio enterovirus activity during the COVID-19 pandemic, Taiwan, 2020 |
Emerging Infectious Diseases. 2021 Jan;27(1):306-308. |
|
2021-01 |
Ser253Leu substitution in PmrB contributes to colistin resistance in clinical Acinetobacter nosocomialis |
Emerging Microbes and Infections. 2021 Jan;10(1):1873-1880. |
|
2020-11-26 |
Clinical and economic impact of intensive care unit-acquired bloodstream infections in Taiwan: A nationwide population-based retrospective cohort study |
BMJ Open. 2020 Nov 26;10(11):Article number e037484. |
|
2020-10 |
Increased mcr-1 in pathogenic Escherichia coli from diseased swine, Taiwan |
Journal of Microbiology, Immunology and Infection. 2020 Oct;53(5):751-756. |
|
2020-09-29 |
Influence of severity of infection on the effect of appropriate antimicrobial therapy for Acinetobacter baumannii bacteremic pneumonia |
Antimicrobial Resistance and Infection Control. 2020 Sep 29;9:Article number 160. |
|
2020-09 |
The effect of preventing subclinical transmission on the containment of COVID-19: Mathematical modeling and experience in Taiwan |
Contemporary Clinical Trials. 2020 Sep;96:Article number 106101. |
|
2020-08 |
Collateral benefit of COVID-19 control measures on influenza activity, Taiwan |
Emerging Infectious Diseases. 2020 Aug;26(8):1928-1930. |
|
2020-07 |
Plasmid- and chromosome-located mcr-3 in mcr-1-positive Escherichia coli in Taiwan |
International Journal of Antimicrobial Agents. 2020 Jul;56(1):Article number 105996. |
|
2020-06 |
Multicentre study of risk factors for mortality in patients with acinetobacter bacteraemia receiving colistin treatment |
International Journal of Antimicrobial Agents. 2020 Jun;55(6):Article number 105956. |
|
2020-03-31 |
Confronting tigecycline-resistant acinetobacter baumannii via Immunization against conserved resistance determinants |
Frontiers in Microbiology. 2020 Mar 31;11:Article number 536. |
|
2020-03 |
Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016 |
International Journal of Antimicrobial Agents. 2020 Mar;55(3):Article number 105883. |
|
2020-02-11 |
Bacterial membrane vesicles from Acinetobacter baumannii induced by ceftazidime are more virulent than those induced by imipenem |
Virulence. 2020 Feb 11;11(1):145-158. |
|
2020-02 |
Policy-driven revolution of prescription record in outpatient use of fluoroquinolones |
Journal of Microbiology, Immunology and Infection. 2020 Feb;53(1):133-140. |
|
2020-01-06 |
Is polymicrobial bacteremia an independent risk factor for mortality in acinetobacter baumannii bacteremia? |
Journal of Clinical Medicine. 2020 Jan 6;9(1):Article number 153. |
|
2020-01 |
A supramolecular trap to increase the antibacterial activity of colistin |
Angewandte Chemie. 2020 Jan;59(4):1430-1434. |
|
2019-12 |
A multicenter study on clinical characteristics of Acinetobacter bacteremia in patients with liver cirrhosis |
Journal of Microbiology, Immunology and Infection. 2019 Dec;52(6):956-965. |
|
2019-10-28 |
Effect of diabetes mellitus on risk of latent TB infection in a high TB incidence area: A community-based study in Taiwan |
BMJ Open. 2019 Oct 28;9(10):Article number e029948. |
|
2019-09 |
Completing circular bacterial genomes with assembly complexity by using a sampling strategy from a single MinION run with barcoding |
Frontiers in Microbiology. 2019 Sep;10:Article number 2068. |
|
2019-07 |
Influenza vaccination and secondary prevention of cardiovascular disease among Taiwanese elders-A propensity score-matched follow-up study |
PLoS ONE. 2019 Jul;14(7):Article number e0219172. |
|
2019-04 |
Molecular epidemiology of emerging carbapenem resistance in acinetobacter nosocomialis and acinetobacter pittii in Taiwan, 2010-2014 |
Antimicrobial Agents and Chemotherapy. 2019 Apr;63(4):e02007-18. |
|
2019-04 |
Overexpression of AdeABC efflux pump associated with tigecycline resistance in clinical Acinetobacter nosocomialis isolates |
Clinical Microbiology and Infection. 2019 Apr;25(4):512.e1-512.e6. |
|
2019-02 |
Multicentre MDR Elizabethkingia anophelis isolates: Novel random amplified polymorphic DNA with capillary electrophoresis systems to rapid molecular typing compared to genomic epidemiology analysis |
Scientific Reports. 2019 Feb;9:Article number 1806. |
|
2019-01-11 |
Use of lipid-lowering agents is not associated with improved outcomes for tuberculosis patients on standard-course therapy: A population-based cohort study |
PLoS ONE. 2019 Jan 11;14(1):Article number e0210479. |
|
2018-12 |
Colistin nanoparticle assembly by coacervate complexation with polyanionic peptides for treating drug-resistant gram-negative bacteria |
Acta Biomaterialia. 2018 Dec;82:133-142. |
|
2018-10 |
Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study |
Journal of Microbiology, Immunology, and Infection. 2018 Oct;51(5):629-635. |
|
2018-08 |
Association between influenza vaccination and the reduced risk of acute kidney injury among older people: A nested case-control study |
European Journal of Internal Medicine. 2018 Aug;54:65-69. |
|
2018-06 |
Risk of mortality of Catheter-Related Bloodstream Infections caused by acinetobacter species: Is early removal of the catheters associated with a better survival outcome? |
Journal of Intensive Care Medicine. 2018 Jun;33(6):361-369. |
|
2018-06 |
Adding a C-terminal Cysteine (CTC) can enhance the bactericidal activity of three different Antimicrobial Peptides |
Frontiers in Microbiology. 2018 Jun;9:Article number 1440. |
|